RLAY FY 2024 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RLAYRelay Therapeutics, Inc.

$2B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M-60.8% YoY

Gross Profit

$10M100.0% margin

Operating Income

-$372M-3722.1% margin

Net Income

-$338M-3374.7% margin

EPS (Diluted)

$-2.36

Cash Flow

Operating Cash Flow

-$249M

Free Cash Flow

-$251M

Stock-Based Comp.

$94M

Balance Sheet

Total Assets

$871M

Total Liabilities

$94M

Stockholders' Equity

$778M

Cash & Equivalents

$124M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$26M	-60.8%
Gross Profit	$10M	$26M	-60.8%
Operating Income	-$372M	-$373M	+0.1%
Net Income	-$338M	-$342M	+1.2%